Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Journal of the American Dietetic Association|January 1, 1983
Growth outcome of the very low-birth-weight infant at one yearJ A Ernst, M J Bull, L Moye, et al.
Genes and Immunity|May 22, 2009
Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case--control studyN Schoof, F von Bonin, I R König, et al.
ESMO Open|August 26, 2021
Fertility preservation and management of pregnancy in melanoma patients requiring systemic therapyJ C Hassel, E Livingstone, J P Allam, et al.
Annals of Surgical Oncology|May 3, 2012
A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremityG M Beasley, A P Coleman, A Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2010
Phase II trial of neoadjuvant temozolomide in resectable melanoma patientsG D Shah, N D Socci, J S Gold, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 13, 2004
Estimating the relative risk of developing melanoma in INK4A carriersM Berwick, I Orlow, S Mahabir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2016
Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trialT K Eigentler, R Gutzmer, A Hauschild, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trialF Egberts, R Gutzmer, S Ugurel, et al.
The British Journal of Dermatology|May 21, 2014
Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safetyJ Malvehy, A Hauschild, C Curiel-Lewandrowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trialJ Guo, R D Carvajal, R Dummer, et al.
Pageof 14